Xue Bai
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 31
- Cancer Immunotherapy and Biomarkers 13
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 4
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
- Co-authors
- Meilan ZhangXuemei ZengZhiwei ZhangZhong‐Yi DongDehua WuFeng LiuXin-Ran TangShuai Guo
- Journals
- BMC Medicine (4 papers)New Journal of Chemistry (3 papers)Journal of Agricultural and Food Chemistry (3 papers)International Journal of Biological Macromolecules (2 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xue Bai
61 papers receiving 983 citations
Peers
Comparison fields: 5 of 102
- Cancer Research 339
- Oncology 337
- Pulmonary and Respiratory Medicine 260
- Molecular Biology 489
- Immunology 118
Countries citing papers authored by Xue Bai
This map shows the geographic impact of Xue Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Bai more than expected).
Fields of papers citing papers by Xue Bai
This network shows the impact of papers produced by Xue Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Bai. The network helps show where Xue Bai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xue Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 7 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 35 | |
| 12 | 2022 | 15 | |
| 13 | 2022 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2022 | 29 | |
| 16 | 2021 | 3 | |
| 17 | 2019 | 233 | |
| 18 | 2018 | 3 | |
| 19 | 2018 | 23 | |
| 20 | 2012 | 16 |
About Xue Bai
Xue Bai is a scholar working on Oncology, Cancer Research, Toxicology, Immunology and Pulmonary and Respiratory Medicine, having authored 68 papers that have together received 990 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Lung Cancer Treatments and Mutations (7 papers), Immunotherapy and Immune Responses (6 papers), Cancer-related molecular mechanisms research (6 papers), Immune Cell Function and Interaction (5 papers), Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (339 citations), Oncology (337 citations), Pulmonary and Respiratory Medicine (260 citations), Molecular Biology (489 citations) and Immunology (118 citations). Xue Bai has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Meilan Zhang, Xuemei Zeng, Zhiwei Zhang, Zhong‐Yi Dong, Dehua Wu, Feng Liu, Xin-Ran Tang, Shuai Guo, Ze-Qin Guo and Hongbo Zhu. Their work appears in journals such as BMC Medicine, New Journal of Chemistry, Journal of Agricultural and Food Chemistry, International Journal of Biological Macromolecules and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.